TRANS-6A-ALPHA-12-BETA-(PARA-TOLYL)-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE
Compound with spectra: 1 NMR
![TRANS-6A-ALPHA-12-BETA-(PARA-TOLYL)-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE](/api/compound/24WAd9pvugn.png?ph=true&h=300&w=458 "TRANS-6A-ALPHA-12-BETA-(PARA-TOLYL)-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE")
| SpectraBase Compound ID | 24WAd9pvugn |
|---|---|
| InChI | InChI=1S/C21H27N3/c1-14-10-12-15(13-11-14)20-16-6-2-3-7-17(16)22-21-23-18-8-4-5-9-19(18)24(20)21/h10-13,18-20H,2-9H2,1H3,(H,22,23)/t18-,19-,20-/m0/s1 |
| InChIKey | VDTWHYPDWSLQFG-UFYCRDLUSA-N |
| Mol Weight | 321.47 g/mol |
| Molecular Formula | C21H27N3 |
| Exact Mass | 321.220498 g/mol |
| Enantiomer InChIKey | VDTWHYPDWSLQFG-VAMGGRTRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
TRANS-6A-ALPHA-12-BETA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE
TRANS-6A-ALPHA-12-ALPHA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE
TRANS-6A-ALPHA-12-ALPHA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE-HYDROCHLORIDE
TRANS-6A-ALPHA-12-BETA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE-HYDROCHLORIDE
1,4-Dimethyl-4a-phenyl-1,4,4a,5,6,7-hexahydro-1,4-epoxynaphthalene
isopropyl 9-(4-methoxyphenyl)-8-oxo-4,5,6,7,8,9-hexahydro[1,2,4]triazolo[5,1-b]quinazoline-2-carboxylate
benzoic acid, 4-(4,6-dihydro-4-(4-methoxyphenyl)-6-oxo-3-(2-thienyl)pyrrolo[3,4-c]pyrazol-5(1H)-yl)-, ethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Structure Elucidation of Pyrimidobenzimidazoles and Fused Derivatives II [1]. Dodecahydrobenzimidazo-[2,1-b]quinazolines and Decahydrobenzimidazo-[2,1-b]benzo[h]quinazolines [2] | Monatshefte für Chemie/Chemical Monthly | 2000 |